TGFB1 and metabolic dysfunction-associated steatotic liver disease: The discovery of the implication of cytokines such as transforming growth factor-beta 1 (TGF-β1), platelet-derived growth factor, and angiotensin II in the pathogenesis of NAFLD led to a study evaluating the use of angiotensin II receptor blockers for exploration of a potential treatment option.